专利检索 ap:("CALLIDITAS THERAPEUTICS SUISSE SA" OR "UNIVERSITY OF SOUTHAMPTON") AND inv:"Philippe Wiesel" 第 1 页

1.

发明授权
Use of NOX inhibitors for treatment of cancer 有权

公开(公告)号：US12011436B2

公开(公告)日：2024-06-18

申请号：US16760910

申请日：2018-11-01

申请人： CALLIDITAS THERAPEUTICS SUISSE SA , UNIVERSITY OF SOUTHAMPTON

发明人： Philippe Wiesel , Freddy Heitz , Gareth Thomas , Christopher Hanley , Kirsty Ford

IPC分类号： A61K31/437 , A61K31/4025 , A61K31/5377 , A61K35/17 , A61K38/19 , A61K39/00 , A61K39/245 , A61K39/395 , A61P35/00

CPC分类号： A61K31/437 , A61K31/4025 , A61K31/5377 , A61K35/17 , A61K38/191 , A61K39/245 , A61K39/3955 , A61P35/00 , A61K2039/505 , A61K2039/507

摘要： The present invention is related to compounds, methods, compositions and uses that are able to restore responsiveness to immunotherapy, in particular immune check point inhibitors or anti-cancer vaccine or to anti-angiogenesis treatment.